Evofem Biosciences IncChange company Symbol lookupSelect an option...EVFM Evofem Biosciences IncRNWWW ReNew Energy Global Equity Warrant Exp 23rd Aug 2026 *W EXP 08/23/2026RVPH Reviva Pharmaceuticals Holdings, Inc.TPR Tapestry IncBGRY Berkshire Grey IncBKNG Booking Holdings IncUHT Universal Health Realty Income TrustBBVA Banco Bilbao Vizcaya Argentaria SARILY B Riley Financial IncWTS Watts Water Technologies IncGo
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. It is engaged in developing and commercializing products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). Its product, Phexxi vaginal gel, is a hormone-free, woman-controlled, on-demand prescription contraceptive gel for women. Its lead clinical program is evaluating Phexxi (using the investigational name EVO100) for the prevention of chlamydia and gonorrhea in women. EVO200 vaginal gel (EVO200), its investigational candidate for the reduction of recurrent bacterial vaginosis (BV), uses the same vaginal potential of hydrogen (pH) modulator platform as Phexxi. It also focuses on developing Multipurpose Prevention Technology (MPT) vaginal gel for indications, including the prevention of human immunodeficiency virus (HIV) in women through Orion Biotechnology Canada Ltd.
|
|
|
|
| |
Upcoming Events
Past Earnings
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
| Date | Event description | Earnings per share actual | Earnings estimate range | Previous year's actual |
|---|---|---|---|---|
| January 6, 2023 | Q3 2022 Earnings Release | -$0.04 | -$0.29 to -$0.21 | -$7.20 |
| August 12, 2022 | Q2 2022 Earnings Release | -$4.57 | -$1.51 to -$0.55 | -$4.05 |
| May 10, 2022 | Q1 2022 Earnings Release | -$2.88 | -$3.60 to -$2.55 | -$8.40 |
| March 3, 2022 | Q4 2021 Earnings Release | -$4.95 | -$0.29 to -$0.13 | -- |
Past Stock Splits
| Date | Event description | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2022 | 1:15 Stock Split | |||||||||
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
, , , Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.